Sudden death in heart failure: Underlying electrophysiological mechanisms

Heart Failure Reviews

Volumn 7, Issue 3, 2002, Pages 255-260

  Krishnan, Subramaniam C ^a   Schuger, Claudio D ^a   Goldstein, Sidney ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; POTASSIUM ION; SODIUM ION; TETRODOTOXIN;

ADRENERGIC SYSTEM; ARRHYTHMOGENESIS; CALCIUM CELL LEVEL; CALCIUM CURRENT; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TOLERABILITY; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HUMAN; LONG QT SYNDROME; METABOLIC DISORDER; POTASSIUM CURRENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLOW INWARD CURRENT; SODIUM CURRENT; SUDDEN DEATH;

ACTION POTENTIALS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HUMANS; RENIN-ANGIOTENSIN SYSTEM; VENTRICULAR DYSFUNCTION, LEFT; WATER-ELECTROLYTE BALANCE;

EID: 0036660404     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020029323635     Document Type: Review

References (24)

1. Goldstein S. Heart failure therapy at the turn of the century. Heart Failure Rev 2001;6:7-14.
2. Stevenson WG, Stevenson LW, Middlekauf H, et al. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993;88:2953-2961.
3. Merit-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-2007.
4. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-1475.
5. Dean JW, Laub MJ. Arrhythmias in heart failure: Role of mechanically induced changes in electrophysiology. Lancet 1989;1309-1311.
6. Meredith IT, Eisenhofer G, Lambert EM, et al. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release. Circulation 1993;88:136-145.
7. Meredith IT, Broughton A, Jennings GL, et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991;325:618-624.
8. Cao J, Chen LS, KenKnight B, et al. Nerve sprouting and sudden cardiac death. Circ Res 2000;86:816-821.
9. Cao J, Fishbein MC, Han JB, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmias. Circulation 2000;101:1960-1969.
10. Antzelevich C, Sicouri S, Litosky S, Krishnan SC, et al. Heterogeneity within the ventricular wall: Electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res 1991;69:1427-1449.
11. Echt DS, Liebson PR, Mitchell LB, et al. Morbidity and mortality in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Eng J Med 1991;324:781-788.
12. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990;82:1124-1129.
13. Marban E. Heart failure: The electrophysiology connection. J Cardiovasc Electrophysiol 1999;10:1425-1428.
14. Gwathmet JK, Copelas L, MacKinnon R, et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-76.
15. Pak PH, Nuss HB, Tunin RS, et al. Repolarization abnormalities, arrhythmias and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol 1997;30:576-584.
16. Berger RD, Kasper EK, Baughman KL, et al. Beat-to-beat QT interval variability: Novel evidence for repolarization liability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997;96:1557-1565.
17. Beuckelmann DJ, Nabauer M, Erdmann E. Alterations of K currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:379-385.
18. Kaab S, Nuss HB, Chiamvimonvat N, et al. Ionic mechanisms of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 1996;78:262-273.
19. Maltsev VA, Sabbah HN, Higgins R, et al. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 1998;98:2545-2552.
20. + channel in human cardiac myocytes: Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation 1995;92:164-174.
21. Nabauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:386-394.
22. 2+ current in cardiomyocytes of dogs with chronic heart failure. J Mol Cell Cardiol 1996;28:A162.
23. Sakakibara Y, Furukawa T, Singer DH, et al. Sodium current in isolated human ventricular myocytes. Am J Physiol 1993;265:H1301-H1309.
24. Piot C, Lemaire S, Albat B, et al. High frequency induced upregulation of human cardiac calcium currents. Circulation 1996;93:120-128.